STING (TMEM173) Human shRNA Lentiviral Particle (Locus ID 340061)
CAT#: TL307876V
LOC340061 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.
Need custom lentivirus service?
Get a free quote
CNY 11400.00
Cited in 2 publications. |
CNY 2950.00
CNY 1999.00
CNY 2700.00
Specifications
Product Data | |
Product Name | STING (TMEM173) Human shRNA Lentiviral Particle (Locus ID 340061) |
Locus ID | 340061 |
Synonyms | ERIS; hMITA; hSTING; MITA; MPYS; NET23; SAVI; STING; STING-beta; TMEM173 |
Vector | pGFP-C-shLenti |
Format | Lentiviral particles |
RefSeq | NM_001301738, NM_198282, NM_198282.1, NM_198282.2, NM_198282.3, NM_001301738.1, BC047779, BC047779.1, BM149879, BM981219, NM_001367258, NM_001301738.2, NM_198282.4 |
Summary | This gene encodes a five transmembrane protein that functions as a major regulator of the innate immune response to viral and bacterial infections. The encoded protein is a pattern recognition receptor that detects cytosolic nucleic acids and transmits signals that activate type I interferon responses. The encoded protein has also been shown to play a role in apoptotic signaling by associating with type II major histocompatibility complex. Mutations in this gene are the cause of infantile-onset STING-associated vasculopathy. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2014] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma
,Falahat, R;Berglund, A;Putney, RM;Perez-Villarroel, P;Aoyama, S;Pilon-Thomas, S;Barber, GN;Mul?, JJ;,
Proceedings of the National Academy of Sciences of the United States of America
,PubMed ID 33827917
[STING1]
|
STING signaling in melanoma cells shapes antigenicity and can promote antitumor T-cell activity
,null,
Cancer immunology research
,PubMed ID 31462408
[STING1]
|
Documents
Product Manuals |
FAQs |
SDS |